Real-Time Ventricular Fibrillation Amplitude-Spectral Area Analysis to Guide Timing of Shock Delivery Improves Defibrillation Efficacy During Cardiopulmonary Resuscitation in Swine

Salvatore Aiello, Michelle Perez, Chad Cogan, Alvin Baetiong, Steven A Miller, Jeejabai Radhakrishnan, Christopher L Kaufman, Raúl J Gazmuri, Salvatore Aiello, Michelle Perez, Chad Cogan, Alvin Baetiong, Steven A Miller, Jeejabai Radhakrishnan, Christopher L Kaufman, Raúl J Gazmuri

Abstract

Background: The ventricular fibrillation amplitude spectral area (AMSA) predicts whether an electrical shock could terminate ventricular fibrillation and prompt return of spontaneous circulation. We hypothesized that AMSA can guide more precise timing for effective shock delivery during cardiopulmonary resuscitation.

Methods and results: Three shock delivery protocols were compared in 12 pigs each after electrically induced ventricular fibrillation, with the duration of untreated ventricular fibrillation evenly stratified into 6, 9, and 12 minutes: AMSA-Driven (AD), guided by an AMSA algorithm; Guidelines-Driven (GD), according to cardiopulmonary resuscitation guidelines; and Guidelines-Driven/AMSA-Enabled (GDAE), as per GD but allowing earlier shocks upon exceeding an AMSA threshold. Shocks delivered using the AD, GD, and GDAE protocols were 21, 40, and 62, with GDAE delivering only 2 AMSA-enabled shocks. The corresponding 240-minute survival was 8/12, 6/12, and 2/12 (log-rank test, P=0.035) with AD exceeding GDAE (P=0.026). The time to first shock (seconds) was (median [Q1-Q3]) 272 (161-356), 124 (124-125), and 125 (124-125) (P<0.001) with AD exceeding GD and GDAE (P<0.05); the average coronary perfusion pressure before first shock (mm Hg) was 16 (9-30), 10 (6-12), and 3 (-1 to 9) (P=0.002) with AD exceeding GDAE (P<0.05); and AMSA preceding the first shock (mV·Hz, mean±SD) was 13.3±2.2, 9.0±1.6, and 8.6±2.0 (P<0.001) with AD exceeding GD and GDAE (P<0.001). The AD protocol delivered fewer unsuccessful shocks (ie, less shock burden) yielding less postresuscitation myocardial dysfunction and higher 240-minute survival.

Conclusions: The AD protocol improved the time precision for shock delivery, resulting in less shock burden and less postresuscitation myocardial dysfunction, potentially improving survival compared with time-fixed, guidelines-driven, shock delivery protocols.

Keywords: amplitude spectral area; animal model; defibrillation; resuscitation; sudden cardiac arrest; ventricular fibrillation; ventricular fibrillation waveform analysis; waveform analysis.

© 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.

Figures

Figure 1
Figure 1
AMSA‐Driven (AD) protocol featuring 1 representative experiment for each shock advisory criterion and the corresponding total number of shocks given guided by such criterion for the entire AD group. Shown in each graph are the AMSA at the time CPR started (AMSAt0) and the time threshold according to: 15−(0.0222·[tcpr−t0]); where t0 is the time at which CPR started and tcpr is the CPR time in seconds with each “step” representing the interval between ventilation pauses during which shock advise and subsequent shock delivery occurred (if advised). The AMSA threshold criterion (A) and AMSA delta criterion (B) are time independent based on reaching an AMSA value ≥15 mV·Hz (AMSA threshold) or having an AMSA increase ≥30% relative to the preceding AMSA value at any time during CPR (AMSA delta). The time threshold criterion (C) and the time maximum criterion (D) are independent of the AMSA level during CPR but dependent on CPR duration, with the time threshold setting a time to advise shock based on AMSAt0 exceeding 15−(0.0222·[tcpr−t0] in seconds) and the time maximum setting a time (360 s) by which a shock must be delivered. As shown by the representative experiments, the threshold criterion (A) and the delta criterion (B) were met before the time threshold criterion. The time threshold criterion was met after failing to meet AMSA threshold or AMSA delta criterion while having an AMSAt0 that enabled shock advice within 360 s (C). When none of the above criteria were met, the time maximum criterion advised shock at 360 s (D). Please refer to the Methods section for the approach developed to reset the algorithm after a shock is advised. AMSA indicates amplitude spectral area; CPR, cardiopulmonary resuscitation.
Figure 2
Figure 2
Swine model of electrically induced VF with resuscitation attempted by conventional CPR using a mechanical piston device and bag‐valve ventilation through an endotracheal tube with delivery of 100% oxygen. CPR indicates cardiopulmonary resuscitation; VF, ventricular fibrillation.
Figure 3
Figure 3
Kaplan–Meier survival curves analyzed from the time VF was induced in all 36 animals (A) and from the time ROSC was achieved in 27 animals (B), comparing the 3 defibrillation protocols: AMSA‐Driven (AD), Guidelines‐Driven (GD), and Guidelines‐Driven/AMSA‐Enabled (GDAE). The overall P value calculated using the log‐rank test is shown in the graph along with the pairwise comparison between AD and GDAE using the Holm–Sidak test. ROSC indicates return of spontaneous circulation; VF, ventricular fibrillation.
Figure 4
Figure 4
Shown are the initial 12 min of the resuscitation effort from the start of CPR (ie, min 0) depicting the main effects of the defibrillation protocols along with differences between animals that achieved ROSC and those that did not. Differences were analyzed by a linear mixed‐effect model treating time as continuous variable to assess the main effects of time (min) and either the defibrillation protocol (DP)—left—or the CPR outcome (ROSC)—right—and their interaction (DP or ROSC×min) and also treating time as a discrete variable to show for descriptive reasons differences at specific moments using the Sidak multiple comparisons pairwise method (left). AD indicates AMSA‐Driven; AMSA, amplitude spectral area; CPP, coronary perfusion pressure; CPR, cardiopulmonary resuscitation; GD, Guidelines‐Driven; GDAE, Guidelines‐Driven/AMSA‐Enabled; ROSC, return of spontaneous circulation. The number of animals receiving CPR at each time measurement is depicted graphically on top of the figure, indicating that only 10 animals remained receiving CPR after 12 min (ie, AD=3/12, GD=2/12, and GDAE=5/12). Arrows denote delivery of epinephrine (EPI) (1 mg into the right atrium) at 4 and 8 min of CPR. The absence of AMSA data in the GD and GDAE groups at 2, 4, 6, 8, 10, and 12 min corresponds to the pauses when electrical shocks were delivered, precluding calculation of AMSA. Data are shown as mean±SEM; “a” different from AD; *P≤0.05, †P≤0.01, and ‡P≤0.001.
Figure 5
Figure 5
First shock analysis showing (A) CPR duration before first shock; (B) Epinephrine given before first shock; (C) Average coronary perfusion pressure (CPP) before first shock; (D) AMSA before first shock; (E) Individual AMSA values showing the AMSA immediately before start of CPR and the corresponding AMSA before shock delivery; with white symbols denoting AMSA‐Driven (AD), black symbols Guidelines‐Driven (GD), and gray symbols Guidelines‐Driven/AMSA‐Enabled (GDAE) and with the duration of untreated VF shown by circles for 6 min, by squares for 9 min, and by diamonds for 12 min (the animal that received a shock after 12 min, had a pulseless electrical activity at the end of untreated VF, and reversed to VF after 7 min if CPR, time at which the AD algorithm was activated); and (F) the first shock outcome determined at the next CPR pause or 18 s later if CPR was not resumed. The CPR duration, epinephrine, and CPP data were analyzed by the Kruskal–Wallis on ranks test and AMSA by 1‐way ANOVA with corresponding tests for pairwise comparisons. The first shock outcome was analyzed by χ2 (*P=0.016). The group data are shown as box plots and means±SD with the P values for the overall test displayed in each graph and the pairwise comparisons denoted by symbols (*P<0.05, ‡P<0.001 vs AD). AMSA indicates amplitude spectral area; CPR, cardiopulmonary resuscitation; PEA, pulseless electrical activity; ROCA, return of cardiac activity; ROSC, return of spontaneous circulation; VF, ventricular fibrillation.
Figure 6
Figure 6
Postresuscitation effects on hemodynamic function. Baseline measurements were obtained 5 min before inducing ventricular fibrillation. Differences were analyzed by a linear mixed‐effect model treating time as continuous variable to assess the main effects of time (min) and defibrillation protocol (DP) and their interaction (DP×min) and treating each time point as a discrete moment for descriptive reasons using the Sidak multiple comparisons pairwise method to identify statistically significant differences among groups at the specific time point. AD indicates AMSA‐driven; AMSA, amplitude spectral area; DO2I, systemic oxygen delivery index; GD, guidelines‐driven; GDAE, guidelines‐driven/AMSA‐enabled; LVSWI, left ventricular stroke work index; MAP, mean aortic pressure; PETCO2, end‐tidal PCO2; VO2I, systemic oxygen consumption index. The data are shown as mean±SEM; “a” different from AD; *P≤0.05 and ‡P≤0.001.
Figure 7
Figure 7
Upper graphs depict the association between AMSA values measured during the pause before shock delivery and the immediate cardiac outcomes for the first shock (A) and for all shocks (B). Differences were analyzed by 1‐way ANOVA followed by the Holm‐Sidak pairwise comparisons test with the P values for the overall test shown in each graph. AMSA indicates amplitude spectral area; AUC, area under the curve; PEA, pulseless electrical activity; ROCA, return of cardiac activity; ROSC, return of spontaneous circulation; VFp, persistence of ventricular fibrillation. The data are shown as mean±SD; “a” different from VFp, “b” different from PEA; *P<0.05, ‡P<0.001. Lower graphs depict the areas under the receiver operator characteristic curves with their 95% confidence intervals shown in brackets for the predictive value of AMSA on the immediate outcome for the first shock outcome (C) and for all shocks (D). The outcome was defined as ROSC or no‐ROSC (ie, ROCA, PEA, or VFp).
Figure 8
Figure 8
A, Histograms showing the distribution of the shocks delivered per animal according to the defibrillation protocol (AD, AMSA‐Driven; GD, Guidelines‐Driven; GDAE, Guidelines‐Driven/AMSA‐Enabled). B, Shock burden (calculated as described in the text) analyzed by Kruskal–Wallis test on ranks followed by the Tukey test for pairwise comparisons, with the data shown in box plots. The P value for the overall test is shown in the graph (*P<0.05 vs AD). C, Linear regression between shock burden and survival time after ROSC, showing the corresponding 95% confidence interval for the regression analysis.1One GD data point is behind 3 AD data points (2 at 240 min and 1 at 237 min); 2Two GD data points are behind 3 AD data points; 3One GD and 1 GDAE data points are behind the 2 AD data points. D, Linear regression between shock burden and LVSWI at 240 min in 15 animals that survived the entire postresuscitation interval, showing the corresponding 95% confidence interval for the regression analysis. Hemodynamic data were lost because of technical issues in 1 AD animal that had zero shock burden and survived 240 min. 1Two superimposed GD data points. AMSA indicates amplitude spectral area; LVSWI, left ventricular stroke work index; ROSC, return of spontaneous circulation.

References

    1. Travers AH, Perkins GD, Berg RA, Castren M, Considine J, Escalante R, Gazmuri RJ, Koster RW, Lim SH, Nation KJ, Olasveengen TM, Sakamoto T, Sayre MR, Sierra A, Smyth MA, Stanton D, Vaillancourt C. Part 3: adult basic life support and automated external defibrillation: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2015;132:S51–S83.
    1. Valenzuela TD, Spaite DW, Meislin HW, Clark LL, Wright AL, Ewy GA. Emergency vehicle intervals versus collapse‐to‐CPR and collapse‐to‐defibrillation intervals: monitoring emergency medical services system performance in sudden cardiac arrest. Ann Emerg Med. 1993;22:1678–1683.
    1. Ekstrom L, Herlitz J, Wennerblom B, Axelsson A, Bang A, Holmberg S. Survival after cardiac arrest outside hospital over a 12‐year period in Gothenburg. Resuscitation. 1994;27:181–187.
    1. Spearpoint KG, McLean CP, Zideman DA. Early defibrillation and the chain of survival in ‘in‐hospital’ adult cardiac arrest; minutes count. Resuscitation. 2000;44:165–169.
    1. Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med. 2000;343:1206–1209.
    1. Gazmuri RJ, Weil MH, von Planta M, Gazmuri RR, Shah DM, Rackow EC. Cardiac resuscitation by extracorporeal circulation after failure of conventional CPR. J Lab Clin Med. 1991;118:65–73.
    1. Cobb LA, Fahrenbruch CE, Walsh TR, Copass MK, Olsufka M, Breskin M, Hallstrom AP. Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out‐of‐hospital ventricular fibrillation. JAMA. 1999;281:1182–1188.
    1. Menegazzi JJ, Wang HE, Lightfoot CB, Fertig KC, Chengelis NL, Sherman LD, Callaway CW. Immediate defibrillation versus interventions first in a swine model of prolonged ventricular fibrillation. Resuscitation. 2003;59:261–270.
    1. Eftestol T, Wik L, Sunde K, Steen PA. Effects of cardiopulmonary resuscitation on predictors of ventricular fibrillation defibrillation success during out‐of‐hospital cardiac arrest. Circulation. 2004;110:10–15.
    1. Meier P, Baker P, Jost D, Jacobs I, Henzi B, Knapp G, Sasson C. Chest compressions before defibrillation for out‐of‐hospital cardiac arrest: a meta‐analysis of randomized controlled clinical trials. BMC Med. 2010;8:52.
    1. Niemann JT, Cairns CB, Sharma J, Lewis RJ. Treatment of prolonged ventricular fibrillation. Immediate countershock versus high‐dose epinephrine and CPR preceding countershock. Circulation. 1992;85:281–287.
    1. Tang W, Weil MH, Sun S, Yamaguchi H, Povoas HP, Pernat AM, Bisera J. The effects of biphasic and conventional monophasic defibrillation on postresuscitation myocardial function. J Am Coll Cardiol. 1999;34:815–822.
    1. Leng CT, Paradis NA, Calkins H, Berger RD, Lardo AC, Rent KC, Halperin HR. Resuscitation after prolonged ventricular fibrillation with use of monophasic and biphasic waveform pulses for external defibrillation. Circulation. 2000;101:2968–2974.
    1. Marn‐Pernat A, Weil MH, Tang W, Pernat A, Bisera J. Optimizing timing of ventricular defibrillation. Crit Care Med. 2001;29:2360–2365.
    1. Povoas HP, Weil MH, Tang W, Bisera J, Klouche K, Barbatsis A. Predicting the success of defibrillation by electrocardiographic analysis. Resuscitation. 2002;53:77–82.
    1. Indik JH, Allen D, Shanmugasundaram M, Zuercher M, Hilwig RW, Berg RA, Kern KB. Predictors of resuscitation in a swine model of ischemic and nonischemic ventricular fibrillation cardiac arrest: superiority of amplitude spectral area and slope to predict a return of spontaneous circulation when resuscitation efforts are prolonged. Crit Care Med. 2010;38:2352–2357.
    1. Firoozabadi R, Nakagawa M, Helfenbein ED, Babaeizadeh S. Predicting defibrillation success in sudden cardiac arrest patients. J Electrocardiol. 2013;46:473–479.
    1. Indik JH, Conover Z, McGovern M, Silver AE, Spaite DW, Bobrow BJ, Kern KB. Association of amplitude spectral area of the ventricular fibrillation waveform with survival of out‐of‐hospital ventricular fibrillation cardiac arrest. J Am Coll Cardiol. 2014;64:1362–1369.
    1. Coult J, Sherman L, Kwok H, Blackwood J, Kudenchuk PJ, Rea TD. Short ECG segments predict defibrillation outcome using quantitative waveform measures. Resuscitation. 2016;109:16–20.
    1. Ristagno G, Mauri T, Cesana G, Li Y, Finzi A, Fumagalli F, Rossi G, Grieco N, Migliori M, Andreassi A, Latini R, Fornari C, Pesenti A. Amplitude spectrum area to guide defibrillation: a validation on 1617 patients with ventricular fibrillation. Circulation. 2015;131:478–487.
    1. Noc M, Weil MH, Gazmuri RJ, Sun S, Bisera J, Tang W. Ventricular fibrillation voltage as a monitor of the effectiveness of cardiopulmonary resuscitation. J Lab Clin Med. 1994;124:421–426.
    1. Salcido DD, Menegazzi JJ, Suffoletto BP, Logue ES, Sherman LD. Association of intramyocardial high energy phosphate concentrations with quantitative measures of the ventricular fibrillation electrocardiogram waveform. Resuscitation. 2009;80:946–950.
    1. Li Y, Ristagno G, Bisera J, Tang W, Deng Q, Weil MH. Electrocardiogram waveforms for monitoring effectiveness of chest compression during cardiopulmonary resuscitation. Crit Care Med. 2008;36:211–215.
    1. Reynolds JC, Salcido DD, Menegazzi JJ. Correlation between coronary perfusion pressure and quantitative ECG waveform measures during resuscitation of prolonged ventricular fibrillation. Resuscitation. 2012;83:1497–1502.
    1. Kolarova J, Ayoub IM, Yi Z, Gazmuri RJ. Optimal timing for electrical defibrillation after prolonged untreated ventricular fibrillation. Crit Care Med. 2003;31:2022–2028.
    1. Sun S, Weng Y, Wu X, Tang K, Ye S, Chen W, Weil MH, Tang W. Optimizing the duration of CPR prior to defibrillation improves the outcome of CPR in a rat model of prolonged cardiac arrest. Resuscitation. 2011;82(suppl 2):S3–S7.
    1. Salcido DD, Kim YM, Sherman LD, Housler G, Teng X, Logue ES, Menegazzi JJ. Quantitative waveform measures of the electrocardiogram as continuous physiologic feedback during resuscitation with cardiopulmonary bypass. Resuscitation. 2012;83:505–510.
    1. Gazmuri RJ, Kaufman CL, Baetiong A, Radhakrishnan J. Ventricular fibrillation waveform changes during controlled coronary perfusion using extracorporeal circulation in a swine model. PLoS One. 2016;11:e0161166.
    1. Kleinman ME, Brennan EE, Goldberger ZD, Swor RA, Terry M, Bobrow BJ, Gazmuri RJ, Travers AH, Rea T. Part 5: adult basic life support and cardiopulmonary resuscitation quality: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132:S414–S435.
    1. Link MS, Berkow LC, Kudenchuk PJ, Halperin HR, Hess EP, Moitra VK, Neumar RW, O'Neil BJ, Paxton JH, Silvers SM, White RD, Yannopoulos D, Donnino MW. Part 7: adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132:S444–S464.
    1. Kelley KW, Curtis SE, Marzan GT, Karara HM, Anderson CR. Body surface area of female swine. J Anim Sci. 1973;36:927–930.
    1. Faybik P, Lahner D, Schramm W. A longstanding error by Ernest Henry Starling (author reply 1584‐5). Resuscitation. 2010;81:1584–1585.
    1. Gazmuri RJ, Whitehouse K, Wittinghill K, Baetiong A, Radhakrishnan J. Vasopressin infusion with small‐volume fluid resuscitation during hemorrhagic shock promotes hemodynamic stability and survival in swine. PLoS One. 2015;10:e0130134.
    1. Gazmuri RJ, Whitehouse K, Whittinghill K, Baetiong A, Shah K, Radhakrishnan J. Early and sustained vasopressin infusion augments the hemodynamic efficacy of restrictive fluid resuscitation and improves survival in a liver laceration model of hemorrhagic shock. J Trauma Acute Care Surg. 2017;82:317–327.
    1. Wang Z, Goonewardene LA. The use of MIXED models in the analysis of animal experiments with repeated measures data. Can J Anim Sci. 2004;84:1–11.
    1. Fitzmaurice GM, Ravichandran C. A primer in longitudinal data analysis. Circulation. 2008;118:2005–2010.
    1. Ayoub IM, Kolarova J, Gazmuri RJ. Cariporide given during resuscitation promotes return of electrically stable and mechanically competent cardiac activity. Resuscitation. 2010;81:106–110.
    1. Borovnik‐Lesjak V, Whitehouse K, Baetiong A, Artin B, Radhakrishnan J, Gazmuri RJ. High‐dose erythropoietin during cardiac resuscitation lessens postresuscitation myocardial stunning in swine. Transl Res. 2013;162:110–121.
    1. Freese JP, Jorgenson DB, Liu PY, Innes J, Matallana L, Nammi K, Donohoe RT, Whitbread M, Silverman RA, Prezant DJ. Waveform analysis‐guided treatment versus a standard shock‐first protocol for the treatment of out‐of‐hospital cardiac arrest presenting in ventricular fibrillation: results of an international randomized, controlled trial. Circulation. 2013;128:995–1002.
    1. Cheng Y, Mowrey KA, Nikolski V, Tchou PJ, Efimov IR. Mechanisms of shock‐induced arrhythmogenesis during acute global ischemia. Am J Physiol Heart Circ Physiol. 2002;282:H2141–H2151.
    1. Nikolski VP, Efimov IR. Electroporation of the heart. Europace. 2005;7(suppl 2):146–154.
    1. Guensch DP, Yu J, Nadeshalingam G, Fischer K, Shearer J, Friedrich MG. Evidence for acute myocardial and skeletal muscle injury after serial transthoracic shocks in healthy swine. PLoS One. 2016;11:e0162245.
    1. Gazmuri RJ, Deshmukh S, Shah PR. Myocardial effects of repeated electrical defibrillations in the isolated fibrillating rat heart. Crit Care Med. 2000;28:2690–2696.
    1. Kato R, Foex P. Myocardial protection by anesthetic agents against ischemia‐reperfusion injury: an update for anesthesiologists. Can J Anaesth. 2002;49:777–791.
    1. Xu P, Wang J, Kodavatiganti R, Zeng Y, Kass IS. Activation of protein kinase C contributes to the isoflurane‐induced improvement of functional and metabolic recovery in isolated ischemic rat hearts. Anesth Analg. 2004;99:993–1000.
    1. Chiari PC, Bienengraeber MW, Pagel PS, Krolikowski JG, Kersten JR, Warltier DC. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol‐3‐kinase signal transduction: evidence for anesthetic‐induced postconditioning in rabbits. Anesthesiology. 2005;102:102–109.

Source: PubMed

3
Subskrybuj